Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada.

Jessica Moe, Jane A Buxton, Yueqiao Elle Wang, Tamara Chavez, Damian Feldman-Kiss, Charotte Marr, Roy A Purssell, Michael Otterstatter
Author Information
  1. Jessica Moe: Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11th Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada. jessica.moe@ubc.ca.
  2. Jane A Buxton: BC Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada.
  3. Yueqiao Elle Wang: Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11th Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
  4. Tamara Chavez: CoVaRR-Net's Indigenous Engagement, Development, and Research Pillar 7, University of British Columbia, 103-1690 Nelson Street, Vancouver, BC, V6G 1M5, Canada.
  5. Damian Feldman-Kiss: Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11th Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
  6. Charotte Marr: Portland Hotel Society, 9 East Hastings Street, Vancouver, BC, V6A 1M9, Canada.
  7. Roy A Purssell: Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11th Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
  8. Michael Otterstatter: BC Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada.

Abstract

BACKGROUND: In British Columbia, Canada, smoking is the most common modality of drug use among people who die of opioid toxicity. We aimed to assess oxygen saturation (SpO) while people smoked opioids during a pilot study that introduced continuous pulse oximetry at overdose prevention services (OPS) sites.
METHODS: This was an observational cohort study, using a participatory design. We implemented our monitoring protocol from March to August 2021 at four OPS. We included adults (≥ 18 years) presenting to smoke opioids. A sensor taped to participants' fingers transmitted real-time SpO readings to a remote monitor viewed by OPS staff. Peer researchers collected baseline data and observed the timing of participants' inhalations. We analyzed SpO on a per-event basis. In mixed-effects logistic regression models, drop in minimum SpO ≤ 90% in the current minute was our main outcome variable. Inhalation in that same minute was our main predictor. We also examined inhalation in the previous minute, cumulative inhalations, inhalation rate, demographics, co-morbidities, and substance use variables.
RESULTS: We recorded 599 smoking events; 72.8% (436/599) had analyzable SpO data. Participants' mean age was 38.6 years (SD 11.3 years) and 73.1% were male. SpO was highly variable within and between individuals. Drop in SpO ≤ 90% was not significantly associated with inhalation in that same minute (OR: 1.2 [0.8-1.78], p = 0.261) or inhalation rate (OR 0.47 [0.20-1.10], p = 0.082). There was an association of SpO drop with six cumulative inhalations (OR 3.38 [1.04-11.03], p = 0.043); this was not maintained ≥ 7 inhalations. Demographics, co-morbidities, and drug use variables were non-contributory.
CONCLUSIONS: Continuous pulse oximetry SpO monitoring is a safe adjunct to monitoring people who smoke opioids at OPS. Our data reflect challenges of real-world monitoring, indicating that greater supports are needed for frontline responders at OPS. Inconsistent association between inhalations and SpO suggests that complex factors (e.g., inhalation depth/duration, opioid tolerance, drug use setting) contribute to hypoxemia and overdose risk while people smoke opioids.

Keywords

References

  1. Addiction. 2020 Oct;115(10):1954-1959 [PMID: 32057141]
  2. Neuropharmacology. 2019 Jun;151:219-226 [PMID: 30735692]
  3. Can J Public Health. 2019 Apr;110(2):210-215 [PMID: 30725386]
  4. Drug Alcohol Depend. 2019 Dec 1;205:107609 [PMID: 31654839]
  5. Addiction. 2010 Apr;105(4):684-5 [PMID: 20403019]
  6. Anesthesiology. 1990 Nov;73(5):826-30 [PMID: 2122773]
  7. Subst Abuse Treat Prev Policy. 2023 May 16;18(1):27 [PMID: 37194018]
  8. Harm Reduct J. 2024 Feb 20;21(1):45 [PMID: 38378610]
  9. J Anal Toxicol. 1994 Oct;18(6):317-30 [PMID: 7823539]
  10. Subst Abuse Treat Prev Policy. 2021 Oct 18;16(1):79 [PMID: 34663374]
  11. Br J Anaesth. 2010 May;104(5):661-3 [PMID: 20400616]
  12. J Psychoactive Drugs. 2003 Oct-Dec;35(4):455-60 [PMID: 14986874]
  13. Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):86-96 [PMID: 16433897]
  14. Int J Drug Policy. 2019 Apr;66:64-72 [PMID: 30708237]
  15. Sleep Med. 2023 Jul;107:171-178 [PMID: 37187080]
  16. Anaesthesia. 1999 Sep;54(9):835-40 [PMID: 10460553]
  17. Drug Alcohol Depend. 2021 Oct 1;227:109003 [PMID: 34482046]
  18. PLoS One. 2015 Oct 23;10(10):e0140995 [PMID: 26495843]
  19. Sleep. 2006 Apr;29(4):564-71 [PMID: 16676791]
  20. Harm Reduct J. 2021 Mar 7;18(1):29 [PMID: 33678163]
  21. Breathe (Sheff). 2015 Sep;11(3):194-201 [PMID: 26632351]
  22. BMC Public Health. 2016 Jun 07;16:476 [PMID: 27266703]

Grants

  1. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  2. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  3. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  4. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  5. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  6. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  7. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR
  8. Op Gr: COVID-19 MH/SU - Developing Innovative Adaptations of Services/Delivery (AWD-016491 CIHR 2020)/CIHR

MeSH Term

Humans
Male
Female
Oximetry
British Columbia
Adult
Analgesics, Opioid
Middle Aged
Drug Overdose
Oxygen Saturation
Pilot Projects
Smoking
Cohort Studies
Oxygen
Harm Reduction

Chemicals

Analgesics, Opioid
Oxygen

Word Cloud

Created with Highcharts 10.0.0SpOOPSinhalationsinhalationusepeopleopioidsoximetryoverdosemonitoringminutesmokingdrugstudypulseyearssmokedatap = 0BritishColumbiaCanadaopioidoxygensaturationcontinuouspreventionservicesobservationalusingparticipants'dropSpO ≤ 90%mainvariablecumulativerateco-morbiditiesvariables383[0ORassociationBACKGROUND:commonmodalityamongdietoxicityaimedassesssmokedpilotintroducedsitesMETHODS:cohortparticipatorydesignimplementedprotocolMarchAugust2021fourincludedadults≥ 18presentingsensortapedfingerstransmittedreal-timereadingsremotemonitorviewedstaffPeerresearcherscollectedbaselineobservedtiminganalyzedper-eventbasismixed-effectslogisticregressionmodelsminimumcurrentoutcomeInhalationpredictoralsoexaminedpreviousdemographicssubstanceRESULTS:recorded599events728%436/599analyzableParticipants'meanage6SD11731%malehighlywithinindividualsDropsignificantlyassociatedOR:128-178]26104720-110]082six[104-1103]043maintained ≥ 7Demographicsnon-contributoryCONCLUSIONS:Continuoussafeadjunctreflectchallengesreal-worldindicatinggreatersupportsneededfrontlinerespondersInconsistentsuggestscomplexfactorsegdepth/durationtolerancesettingcontributehypoxemiariskPhysiologicresponsesopioids:HarmreductionOpioidOxygenPulseSmoking

Similar Articles

Cited By